Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reiterated by equities research analysts at FinnCap in a research note issued to investors on Tuesday. They currently have a GBX 202 ($3.44) price target on the stock. FinnCap’s target price would indicate a potential upside of 55.09% from the company’s current price.

VEC has been the subject of a number of other recent research reports. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Tuesday, June 17th. They now have a GBX 192 ($3.27) price target on the stock. Separately, analysts at Berenberg Bank raised their price target on shares of Vectura Group PLC from GBX 200 ($3.40) to GBX 210 ($3.57) in a research note on Friday, June 13th. They now have a “buy” rating on the stock. Finally, analysts at Berenberg Bank raised their price target on shares of Vectura Group PLC from GBX 200 ($3.40) to GBX 210 ($3.57) in a research note on Friday, May 30th. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of GBX 175.25 ($2.98).

Vectura Group PLC (LON:VEC) traded down 1.33% on Tuesday, hitting GBX 130.25. 530,406 shares of the company’s stock traded hands. Vectura Group PLC has a 52-week low of GBX 76.00 and a 52-week high of GBX 171.50. The stock has a 50-day moving average of GBX 132.4 and a 200-day moving average of GBX 143.6. The company’s market cap is £520.5 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.